GERON CORP - 8-K Filing
Geron Corporation discontinues Phase 3 IMpactMF trial of imetelstat following recommendation from independent Data Monitoring Committee. (Items: 8.01 Other Events On October 28, 2026, Geron Corporation (the “Company”) issued a press release announcing an update on the Phase 3 IMpactMF trial, 9.01 Financial Statements and Exhibits)
Tickers: $GERN
Read the full article at SEC EDGAR
Part of the story GERON CORP - 8-K Filing (3 articles)